Tori Votaw: Personalising Addiction Treatment with Precision Medicine
We need to make sure that we're not treating all clients the same, and I think this is really like a dialectic.
Imagine a world where addiction treatment is as unique as the individuals seeking help. That's the vision Tori Votaw shares in this episode of 'The Addiction Psychologist'. Hosts Dr. Noah Emery and Samuel Acuff sit down with Tori, a graduate student and T32 predoctoral fellow at the University of New Mexico, to discuss her groundbreaking work in precision medicine for substance use disorders.
Tori dives into the concept of addiction phenotypes—traits like negative emotionality and executive functioning—that can help tailor treatments to specific subgroups. This approach aims to move beyond the one-size-fits-all model, offering more effective, personalised interventions. She explains how current treatments, while evidence-based, often fall short due to their moderate efficacy. Precision medicine seeks to change that by pairing individuals with the most suitable therapies based on their unique characteristics.
Throughout the conversation, Tori and the hosts explore the challenges of standardised treatment methods and the necessity of listening to patients' unique experiences. They discuss the importance of dialectical approaches and ensuring that research measures are unbiased across different groups. Tori also touches on the need to rethink recruitment methods and address issues of mistrust in research, especially among underrepresented communities.
If you're curious about how science is paving the way for more personalised addiction treatments, this episode is a must-listen. It's an eye-opening discussion that highlights the potential of precision medicine to revolutionise substance use disorder treatment.